• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join Us
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page

The regulatory framework for microbiome-based therapies: insights into European regulatory developments

by Camille Bello | May 16, 2025 | PRI Publications

Julie Rodriguez, Magali Cordaillat-Simmons, Bruno Pot, Céline Druart. NPJ Biofilms Microbiomes. 2025 Mar 28;11(1):53. doi: 10.1038/s41522-025-00683-0.  Abstract: The emergence of a broad spectrum of microbiome-based therapies has triggered changes in European...

Recent News & Events

  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille
  • Céline Druart appointed PRI Executive Director following Magali Cordaillat-Simmons’ decision to step down

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu